CD4 and type 1 diabetes mellitus: In light of this, the current study was designed to probe the attributes of PTM epitope specific CD4+ T cells in a cross-sectional cohort of subjects with T1D with either high or low levels of residual c-peptide and in at-risk subjects with single or multiple autoantibodies.